While tumoral membranous expression of PD-L1 is often used as the criterion for PD-L1 positivity in cancers, such as NSCLC,19 renal cell carcinoma20 and melanoma,21 we found no association between tumoral PD-L1 expression and outcome. This evidence concerns the gene CD274 and cancer.